North China Pharmaceutical Co (SHSE:600812) Other Operating Expense : ¥429 Mil (TTM As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is North China Pharmaceutical Co Other Operating Expense?

North China Pharmaceutical Co's Other Operating Expense for the three months ended in Mar. 2024 was ¥18 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥429 Mil.

North China Pharmaceutical Co's quarterly Other Operating Expense increased from Sep. 2023 (¥-164 Mil) to Dec. 2023 (¥383 Mil) but then declined from Dec. 2023 (¥383 Mil) to Mar. 2024 (¥18 Mil).

North China Pharmaceutical Co's annual Other Operating Expense increased from Dec. 2021 (¥396 Mil) to Dec. 2022 (¥423 Mil) and increased from Dec. 2022 (¥423 Mil) to Dec. 2023 (¥430 Mil).

North China Pharmaceutical Co Other Operating Expense Historical Data

The historical data trend for North China Pharmaceutical Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

North China Pharmaceutical Co Other Operating Expense Chart

North China Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

406.92

331.17

395.84

422.79

429.53

North China Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															18.48	192.66	-164.26	382.66	17.57

North China Pharmaceutical Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥429 Mil.

North China Pharmaceutical Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of North China Pharmaceutical Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

North China Pharmaceutical Co (SHSE:600812) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » North China Pharmaceutical Co Ltd (SHSE:600812) » Definitions » Other Operating Expense

Traded in Other Exchanges

N/A

Address

No. 388 Heping East Road, Shijiazhuang, Hebei, CHN, 050015

Website

http://www.ncpc.com

North China Pharmaceutical Co Ltd is engaged in the manufacture and sale of antibiotics, vitamins, and pharmaceutical products in China. The main products include antibiotics such as penicillin, vitamins, cephalosporins, streptomycin, biotechnological drugs, new preparations, and biological products.

Executives

Gao Ren Long	senior management
Lian Fa Zhe	Director

North China Pharmaceutical Co (SHSE:600812) Headlines

No Headlines